Muthiah Vaduganathan

134PUBLICATIONS

325CO-AUTHORS

Cardiology (incl. cardiovascular diseases)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Epidemiological modellingRespiratory diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (134)

Sort by Publication Date:

|Jun 26, 2026

Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD.

|Jun 23, 2026

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

|Jun 15, 2026

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

|Jun 05, 2026

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|May 28, 2026

Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis.

|May 15, 2026

Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial.

Pageof 23

Frequent Collaborators

43 joint publications

Scott D Solomon

40 joint publications

John Jv McMurray

34 joint publications

Pardeep S Jhund

32 joint publications

Brian L Claggett

28 joint publications

Akshay S Desai

24 joint publications

Faiez Zannad

23 joint publications

Carolyn Sp Lam

21 joint publications

Hiddo J L Heerspink

17 joint publications

John W Ostrominski

16 joint publications

Brendon L Neuen